Cita APA

Bruni, S., de Martino, M., Mauro, F. L., Mercogliano, M. F., Proietti Anastasi, C. J., Cordo Russo, R. I., . . . Schillaci, R. (2022). Blocking soluble TNFα sensitizes HER2-positive breast cancer to trastuzumab through MUC4 downregulation and subverts immunosuppression. Web

Citación estilo Chicago

Bruni, Sofia, Mara de Martino, Florencia L. Mauro, María Florencia Mercogliano, Cecilia Jazmín Proietti Anastasi, Rosalia Ines Cordo Russo, Patricia Virginia Elizalde, and Roxana Schillaci. Blocking Soluble TNFα Sensitizes HER2-positive Breast Cancer to Trastuzumab Through MUC4 Downregulation and Subverts Immunosuppression. 2022.

Cita MLA

Bruni, Sofia, et al. Blocking Soluble TNFα Sensitizes HER2-positive Breast Cancer to Trastuzumab Through MUC4 Downregulation and Subverts Immunosuppression. 2022.